Sign In
Buy CBL
$47.48
-1.01 (-2.08%)
At Close: Jun 03, 2026
Winners And Losers Of REIT Earnings Season
08:00am, Friday, 14'th Nov 2025
Over 200 U.S. REITs and homebuilders have reported third-quarter earnings results over the past five weeks, providing critical information on the state of the commercial and residential real estate in
CBL Stock Rises as Q3 Earnings and Leasing Momentum Strengthen
02:06pm, Tuesday, 11'th Nov 2025
CBL reports sharp third-quarter 2025 earnings growth, lifted by property gains, leasing momentum and rising portfolio occupancy.
REIT Replay: REIT Indexes Outperform Broader Markets During 1st Week Of November
07:41am, Tuesday, 11'th Nov 2025
Indexes tracking real estate investment trust stocks outperformed the broader stock market indexes during the first week of November. The Dow Jones Equity All REIT closed the recent week up 1.40%, whi
When The Stimulus Stops
09:00am, Sunday, 09'th Nov 2025
U.S. equity markets stumbled this week as stretched tech valuations collided with weakening consumer and labor market data, while the economic drag and uncertainty from the ongoing government shutdown
CBL & Associates Properties: Solid Q3 2025 Results Ahead Of Shutdown Uncertainty
04:13pm, Friday, 07'th Nov 2025
Roughly 70% of CBL's enterprise value is funded with net debt, with recent share price strength and a Q4 2025 disposal negating the impact of Q3 2025 acquisitions. CBL's tenant sales, occupancy, leasi
SAN FRANCISCO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation therapies to treat cancer an
CBL Properties Reports Results for Third Quarter 2025
04:15pm, Thursday, 06'th Nov 2025
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--CBL Properties (NYSE: CBL) announced results for the third quarter ended September 30, 2025. Results of operations as reported in the consolidated financial statem
CBL Properties Celebrates Opening of Primark at CoolSprings Galleria in Nashville, Tennessee
09:00am, Thursday, 06'th Nov 2025
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--CBL Properties (NYSE:CBL) today announced that Primark has officially opened its doors at CoolSprings Galleria in Nashville, Tennessee. This addition marks the sec
CBL Properties Reloads and Extends Its $25 Million Stock Repurchase Plan
05:15pm, Wednesday, 05'th Nov 2025
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--CBL Properties (NYSE:CBL) today announced that its Board of Directors authorized a new stock repurchase program for the Company to buy up to $25 million of its com
CBL Properties Declares Fourth Quarter Regular Cash Dividend
04:15pm, Wednesday, 05'th Nov 2025
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--CBL Properties (NYSE:CBL) today announced that its Board of Directors has declared a regular cash dividend of $0.45 per common share for the quarter ending Decembe
Head-To-Head Analysis: CBL International (NASDAQ:BANL) versus Universal Logistics (NASDAQ:ULH)
02:54am, Tuesday, 04'th Nov 2025
Universal Logistics (NASDAQ: ULH - Get Free Report) and CBL International (NASDAQ: BANL - Get Free Report) are both small-cap transportation companies, but which is the better stock? We will compare t
REIT Lessons That Could Save You Thousands
08:15am, Monday, 03'rd Nov 2025
Many REITs are bad investments. This is a sector in which you need to be very selective. I share five key lessons from over a decade of REIT investing that will help you avoid losers and improve your
Fed Cuts, Yields Jump, REITs Dip
09:00am, Sunday, 02'nd Nov 2025
U.S. equity markets posted mixed performance this week- while long-term yields jumped- after the Federal Reserve cut short-term rates for a second-straight meeting, but reigned in expectations for fut
CBL Properties Announces Sale of Its Interest in Fremaux Town Center in Slidell, LA
11:10am, Friday, 24'th Oct 2025
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--CBL Properties (NYSE:CBL) today announced that it had closed on the sale of its interest in Fremaux Town Center, a roughly 640,000-square-foot open-air center loca
NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies
